北大医药
(000788)
| 流通市值：33.02亿 | | | 总市值：33.02亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 841,755,296.03 | 819,867,227.23 | 938,341,999.39 | 909,299,481.2 |
| 交易性金融资产 | 280,623,303.71 | 210,040,445.07 | 27,755,723.94 | - |
| 应收票据及应收账款 | 236,824,052.07 | 262,200,329.65 | 280,153,404.34 | 503,216,149.65 |
| 其中：应收票据 | 14,024,947.97 | 15,942,282.33 | 12,162,051 | 16,430,309.36 |
| 应收账款 | 222,799,104.1 | 246,258,047.32 | 267,991,353.34 | 486,785,840.29 |
| 应收款项融资 | 23,631,042.5 | 63,797,961.37 | 25,818,737.82 | 40,162,310.45 |
| 预付款项 | 8,932,840.32 | 8,475,026.8 | 18,113,764.37 | 9,768,402.24 |
| 其他应收款合计 | 47,760,283.25 | 47,072,351.32 | 60,604,738.45 | 59,947,706.74 |
| 存货 | 136,539,766.34 | 121,491,914.33 | 115,497,387.34 | 134,606,178.08 |
| 其他流动资产 | 12,041,516.9 | 10,900,352.24 | 9,597,207.4 | 5,474,639.24 |
| 流动资产合计 | 1,588,108,101.12 | 1,543,845,608.01 | 1,475,882,963.05 | 1,662,474,867.6 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 22,022,300 | 22,022,300 | 22,022,300 | - |
| 投资性房地产 | 25,505,262.47 | 26,009,205.5 | 14,049,740.35 | 14,376,478.51 |
| 固定资产 | 95,440,481.48 | 104,994,134.99 | 117,466,082.17 | 122,596,786.23 |
| 在建工程 | - | - | 3,906,264.61 | 2,262,016.82 |
| 使用权资产 | 84,327,072.61 | 88,729,190.18 | 93,705,374.3 | 17,016,815.13 |
| 无形资产 | 81,355,379.43 | 83,844,897.72 | 93,680,627.04 | 90,165,882.99 |
| 开发支出 | 7,186,266.69 | 6,829,669.97 | 14,678,701.42 | 19,878,780.76 |
| 长期待摊费用 | 301,016.91 | 319,830.48 | 338,644.05 | 357,457.62 |
| 递延所得税资产 | 9,877,620.3 | 9,613,715.59 | 8,737,320.71 | 17,246,110.37 |
| 其他非流动资产 | 39,793,636.58 | 36,687,070.72 | 41,293,915.73 | 46,440,689.43 |
| 非流动资产合计 | 365,809,036.47 | 379,050,015.15 | 409,878,970.38 | 330,341,017.86 |
| 资产总计 | 1,953,917,137.59 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 |
| 流动负债: | | | | |
| 短期借款 | - | 5,118,625.93 | 3,435,981.26 | 5,942,460.44 |
| 应付票据及应付账款 | 179,533,432.85 | 161,410,976.27 | 157,006,895.65 | 192,167,443.44 |
| 其中：应付票据 | 56,574,421.88 | 42,152,117.38 | 42,088,777.54 | 49,574,604.84 |
| 应付账款 | 122,959,010.97 | 119,258,858.89 | 114,918,118.11 | 142,592,838.6 |
| 合同负债 | 5,757,456.26 | 6,667,872.76 | 8,825,233.26 | 9,793,163.35 |
| 应付职工薪酬 | 35,102,690.1 | 28,057,027.2 | 24,207,535.77 | 46,620,579.27 |
| 应交税费 | 4,949,735.08 | 7,428,250.77 | 3,559,640.47 | 3,589,178.67 |
| 其他应付款合计 | 105,863,554.06 | 95,568,677.25 | 95,697,113.33 | 95,633,490.57 |
| 应付股利 | 11,919,748.5 | - | - | - |
| 一年内到期的非流动负债 | 19,321,448.94 | 19,651,802.85 | 19,659,574.57 | 13,620,196.83 |
| 其他流动负债 | 748,469.31 | 868,540.51 | 1,150,081.16 | 1,268,663.62 |
| 流动负债合计 | 351,276,786.6 | 324,771,773.54 | 313,542,055.47 | 368,635,176.19 |
| 非流动负债: | | | | |
| 租赁负债 | 62,046,350.67 | 64,170,972.33 | 66,082,739.11 | 3,544,743.38 |
| 预计负债 | 1,704,066.55 | 1,695,298.32 | 2,319,688.48 | 43,113,418.75 |
| 递延收益 | 15,888,489.37 | 15,480,240.77 | 15,714,636.01 | 16,272,893.17 |
| 递延所得税负债 | - | - | - | 17,242.12 |
| 非流动负债合计 | 79,638,906.59 | 81,346,511.42 | 84,117,063.6 | 62,948,297.42 |
| 负债合计 | 430,915,693.19 | 406,118,284.96 | 397,659,119.07 | 431,583,473.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 595,987,425 | 595,987,425 | 595,987,425 | 595,987,425 |
| 资本公积 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 |
| 盈余公积 | 86,942,774.5 | 86,942,774.5 | 86,942,774.5 | 86,942,774.5 |
| 未分配利润 | 641,544,693.14 | 635,320,586.94 | 606,646,063.1 | 679,775,660.59 |
| 归属于母公司股东权益合计 | 1,523,647,827.52 | 1,517,423,721.32 | 1,488,749,197.48 | 1,561,878,794.97 |
| 少数股东权益 | -646,383.12 | -646,383.12 | -646,383.12 | -646,383.12 |
| 股东权益合计 | 1,523,001,444.4 | 1,516,777,338.2 | 1,488,102,814.36 | 1,561,232,411.85 |
| 负债和股东权益合计 | 1,953,917,137.59 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |